Samsung Reveals Ground-Breaking Blood Glucose Monitoring To Outdo Apple Watch
Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...
Abbott banks on glucose monitors, new launches to ride out China, currency hit
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...
Larry Magid: Testing prescription, over-the-counter continuous glucose monitors
A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...
Abbott forecasts in line annual profit on medical device sales
Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...
Vietnam Investment Reviev13d
Abbott's life-changing tech Lingo wins 2025 innovation award
Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device that helps people ...
Future Market Insights2d
Global Lancet Market Set for Robust Growth, Projected to Reach USD 3.7 Billion by 2033
With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...
drugdeliverybusiness8d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
MassDevice8d
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
The Gazette8d
Abbott banks on glucose monitors, new launches to ride out China, currency hit
which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor.